Three examples of Wisconsin’s growing cluster of cancer drug development and treatment companies will be featured at the Tuesday, April 28 luncheon meeting of the Wisconsin Innovation Network in Madison. A number of Madison-area companies, as well as related research institutions, are working on cancer...
Prodesse Inc. has received approval from the U.S. Food and Drug Administration to sell ProGastro Cd, a diagnostic tool used to detect toxic strains of the bacterial infection colostridium difficile, or c. difficile, a source of 500,000 U.S. infections anually. This tool can produce a...
I am delighted to launch the Fusion Healthcare Blog http://mikeklein.fusionhealthcare.com as a forum for health information technology buyers, users, integrators,investors and developers. We want you to be part of the discussion This blog will co-exist with WTN Media's Digital Healthcare Conferences. The next event...
Today, on Tax Day, President Obama will meet with several working families, just like the ones all across America, who are facing tough choices during this economic crisis. President Obama underscored his commitment to a simpler tax code that rewards work and the pursuit...
A Wisconsin-based company focused on stem cell cytogenetics and characterization has secured special state loan and earns highly sought after certification in state’s angel investor tax credit program Cell Line Genetics, LLC, has secured a $250,000 loan through Wisconsin’s Technology Venture Fund program. Additionally,...
Prodesse Inc. said it has applied with the U.S. Food and Drug Administration to sell its ProParaflu+ diagnostic product in the United States. It is used as an in vitro diagnostic tool for rapid detection and differentiation of parainfluenza viruses 1, 2 and 3. ProParaflu+...
IBM and InSite today announced a $15 million deal to that will help hospitals, doctors and pharmaceutical companies to use a cloud computing based medical imaging database system. This service will support new ways to use cloud computing to manage anticipated increases in medical...
A Madison-based biopharmaceutical firm will today release the results of a drug it is testing that will stop the progression of Alzheimers disease. Mithridion Inc., has completed Phase I of its clinical trial for MCD-386, an M1 drug that has the potential to improve memory...
A Madison stem cell research company has received a $250,000 Technology Venture Fund loan, Wisconsin Governor Jim Doyle announced today. The firm will use the funds to develop two new technologies for stem cell research. The state Department of Commerce has also certified the...
The concept of Digital Healthcare is working its way into our day-to-day vernacular particularly given the push by our new U.S. President, who has vowed that the U.S. healthcare system will be digitalized during the next 5 years. But for the layman what does this...